Biocon, India's largest biotherapeutics firm, is planning to hire around 1000 people in the coming months.

PLX-PAD, stem cell therapy for the treatment of critical limb ischemia (CLI) and end-stage of peripheral artery disease (PAD) by Pluristem Therapeutics, has been found safe in human trials.

Sanofi Aventis-owned Shantha Biotech is recalling five-in-one vaccines Shan5 from across global markets following safety concerns.

Lucentis (ranibizumab) may come as new treatment for vision loss due to diabetes, according to the findings from a new study.